Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 February 2019 | Story Zama Feni | Photo Charl Devenish
Disease Control and Prevention InStory
From left, seated: Dr Mathew Esona, CDC delegate; Dr Michael Bowen, CDC delegate; Dr Martin Nyaga, lead Researcher at the UFS-NGS Unit; standing: Mojalefa Buti, Office of the Vice-Dean, UFS Faculty of Health Sciences; Dr Glen Tylor, Senior Director, Directorate Research Development; Cornelius Hagenmeier, Director, Office for International Affairs; and Dr Saheed Sabiu, Postdoctoral Research Fellow in the Faculty of Natural and Agricultural Sciences.

In pursuit of efforts to advance research on viruses and disease control, the United States-based Centre for Disease Control and Prevention (CDC) has made a commitment to enhance the University of the Free State (UFS) Next Generation Sequencing (NGS) Unit’s data collection systems and further empower its staff and students.

UFS and US guests explore areas of mutual; cooperation

During a visit to the university in early December last year CDC delegation, Dr Michael Bowen and Dr Mathew Esona, a meeting was held with the lead Researcher at the UFS-NGS Unit, Dr Martin Nyaga; Senior Director of the UFS Directorate Research Development, Dr Glen Tylor; Director of UFS Office for International Affairs, Cornelius Hagenmeier; and Dr Saheed Sabiu Postdoctoral Research Fellow in the Faculty of Natural and Agriculture Sciences. It was in this meeting that areas of mutual collaboration and engagement between the two institutions which include technology transfer, funding and wet and dry laboratory quality control and capacity development were identified.

The UFS-NGS Unit, established in 2016, enjoys longstanding networking and collaborative ventures with renowned researchers in Africa, the USA, and Europe – which in return, have contributed immensely to the research activities of the university as a whole.

Dr Nyaga said in an effort to advance genomics research in the NGS Unit, the visitors have committed themselves to initiate and further enhance capacity development for the unit’s staff and students.

US guests impressed with advanced equipment at UFS

The CDC delegation were intrigued that the UFS also operates a Miseq Illumina platform like the one used at their enteric-viruses laboratory. It could thus be in line to assist in developing exclusive pipelines for the analysis of NGS data generated by the UFS-NGS Unit.

This is a personal sequencing system, which is a powerful state-of-the-art next-generation sequencer. It uses sequencing-by-synthesis technology capable of sequencing up to 15GB of high-quality filtered bases per run, with up to 600 base-pair read lengths. This allows the assembly of small genomes or the detection of target variants with unmatched accuracy, especially within homo-polymer regions.

UFS and CDC engagements still on

Further engagements about the identified areas of collaboration are ongoing between Hagenmeier, Dr Bowen, and Dr Nyaga, who are currently working on appropriate mechanisms to enact the envisaged collaboration between the two institutions.

The NGS Unit received research awards from the World Health Organisation, South African Medical Research Council, Poliomyelitis Research Foundation, and the National Research Foundation for different aspects of genomics research, and more recently from the Bill and Melinda Gates Foundation for the Enteric Viruses Genome Initiative, involving four African countries (South Africa, Ghana, Malawi, and Cameroon).

News Archive

UFS gets support for improving university access and success in South Africa
2013-10-24

 

Members of the SASSE Research team are from left: Carike Jordaan, Dr Francois Strydom, Lana Swart, Seisho Gaboutlwelweboutlwelwakemo, Michael Henn en Katleho Nyaile.
Photo: Supplied
24 October 2013

The university’s Centre of Teaching and Learning (CTL) received a grant for US$820 000 (about R8 million) from the Kresge Foundation for their South African Survey of Student Engagement (SASSE) research team.

The SASSE research team is committed to furthering student access with success by promoting quality teaching and learning institutionally and promoting collective impact around student success nationally.

Through this three-year project, the SASSE team aims to provide a range of deeply contextualised and globally benchmarked student engagement measures that can be used at institutional and module/course level for the South African context. The data from these measures can be used to improve the quality of undergraduate teaching and learning, and participating institutions will have access to appropriate capacity development interventions to empower them to use the data to promote evidence-based change in their institutions.

Dr Francois Strydom, Academic Director at the CTL, says the lessons from this higher-education project could be used to develop a stronger post-school sector which could help the country to deal with the massive challenge of youth unemployment; thereby promoting equity, social justice and a prosperous democracy in South Africa.

The Kresge Foundation is a private philanthropic foundation in the United States, which is focused on creating opportunity for low-income people through various programmes. This three-year project forms part of the Kresge Foundation’s Education Programme, which focuses on promoting access and success at South African universities. Therefore the SASSE project aims to contribute to the Kresge-sponsored Access and Success in Higher Education in South Africa (ASHESA), to promote a national conversation on improving student success.

In January this year, the university was one of four South African universities selected to take part in a multi-million rand programme to bolster private fund-raising and advancement efforts. For this programme the UFS was granted US$640 000 (about R5,6 million) over a period of five years.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept